About three years ago, Steven Adler was running the privacy consulting practice at IBM. As he talked with IBM customers, he discovered that many of the large customers had some pretty complex IT ...

The biopharmaceutical industry is at a critical inflection point. It is beset by immense pressure to shorten drug development timelines, reduce staggering costs, and deliver novel therapies for areas ...

By Divine AKOTIAFor decades, donor governments have struggled to translate development intent into tangible results in Ghana. Billions have been committed, feasibility studies commissioned, and ...